These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 37140976)

  • 21. Amaryllidaceae-Type Alkaloids from
    Sancha SAR; Gomes AV; Loureiro JB; Saraiva L; Ferreira MJU
    Molecules; 2022 Sep; 27(18):. PubMed ID: 36144504
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Co-Delivery of Ylang Ylang Oil of
    Sedky NK; Abdel-Kader NM; Issa MY; Abdelhady MMM; Shamma SN; Bakowsky U; Fahmy SA
    Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37176099
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dual-targeted hybrid nanoparticles of synergistic drugs for treating lung metastases of triple negative breast cancer in mice.
    Zhang T; Prasad P; Cai P; He C; Shan D; Rauth AM; Wu XY
    Acta Pharmacol Sin; 2017 Jun; 38(6):835-847. PubMed ID: 28216624
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clathrin-mediated endocytic uptake of PUFA enriched self-nanoemulsifying lipidic systems (SNELS) of an anticancer drug against triple negative cancer and DMBA induced preclinical tumor model.
    Khurana RK; Kumar R; Gaspar BL; Welsby G; Welsby P; Kesharwani P; Katare OP; Singh KK; Singh B
    Mater Sci Eng C Mater Biol Appl; 2018 Oct; 91():645-658. PubMed ID: 30033299
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pyrazole Derivatives Induce Apoptosis via ROS Generation in the Triple Negative Breast Cancer Cells, MDA-MB-468.
    Ashourpour M; Mostafavi Hosseini F; Amini M; Saeedian Moghadam E; Kazerouni F; Arman SY; Shahsavari Z
    Asian Pac J Cancer Prev; 2021 Jul; 22(7):2079-2087. PubMed ID: 34319030
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeted treatment of triple-negative-breast cancer through pH-triggered tumour associated macrophages using smart theranostic nanoformulations.
    Scialla S; Hanafy MS; Wang JL; Genicio N; Costa Da Silva M; Costa M; Oliveira-Pinto S; Baltazar F; Gallo J; Cui Z; Bañobre-López M
    Int J Pharm; 2023 Feb; 632():122575. PubMed ID: 36603672
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aminoflavone-loaded EGFR-targeted unimolecular micelle nanoparticles exhibit anti-cancer effects in triple negative breast cancer.
    Brinkman AM; Chen G; Wang Y; Hedman CJ; Sherer NM; Havighurst TC; Gong S; Xu W
    Biomaterials; 2016 Sep; 101():20-31. PubMed ID: 27267625
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-EGFR anchored paclitaxel loaded PLGA nanoparticles for the treatment of triple negative breast cancer. In-vitro and in-vivo anticancer activities.
    Venugopal V; Krishnan S; Palanimuthu VR; Sankarankutty S; Kalaimani JK; Karupiah S; Kit NS; Hock TT
    PLoS One; 2018; 13(11):e0206109. PubMed ID: 30408068
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting EGFR of triple-negative breast cancer enhances the therapeutic efficacy of paclitaxel- and cetuximab-conjugated nanodiamond nanocomposite.
    Liao WS; Ho Y; Lin YW; Naveen Raj E; Liu KK; Chen C; Zhou XZ; Lu KP; Chao JI
    Acta Biomater; 2019 Mar; 86():395-405. PubMed ID: 30660004
    [TBL] [Abstract][Full Text] [Related]  

  • 30. pH-Responsive Hyaluronic Acid Nanoparticles for Enhanced Triple Negative Breast Cancer Therapy.
    Zeng X; Wang H; Zhang Y; Xu X; Yuan X; Li J
    Int J Nanomedicine; 2022; 17():1437-1457. PubMed ID: 35369031
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Flavonoid calycopterin triggers apoptosis in triple-negative and ER-positive human breast cancer cells through activating different patterns of gene expression.
    Moradi M; Gholipour H; Sepehri H; Attari F; Delphi L; Arefian E; Moridi Farimani M
    Naunyn Schmiedebergs Arch Pharmacol; 2020 Nov; 393(11):2145-2156. PubMed ID: 32617603
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis, Crystal Study, and Anti-Proliferative Activity of Some 2-Benzimidazolylthioacetophenones towards Triple-Negative Breast Cancer MDA-MB-468 Cells as Apoptosis-Inducing Agents.
    Abdel-Aziz HA; Eldehna WM; Ghabbour H; Al-Ansary GH; Assaf AM; Al-Dhfyan A
    Int J Mol Sci; 2016 Jul; 17(8):. PubMed ID: 27483243
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiproliferative and antimetastatic properties of 3-benzyloxy-16-hydroxymethylene-estradiol analogs against breast cancer cell lines.
    Sinka I; Kiss A; Mernyák E; Wölfling J; Schneider G; Ocsovszki I; Kuo CY; Wang HC; Zupkó I
    Eur J Pharm Sci; 2018 Oct; 123():362-370. PubMed ID: 30010030
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phytochemical profile and antiproliferative effect of Ficus crocata extracts on triple-negative breast cancer cells.
    Sánchez-Valdeolívar CA; Alvarez-Fitz P; Zacapala-Gómez AE; Acevedo-Quiroz M; Cayetano-Salazar L; Olea-Flores M; Castillo-Reyes JU; Navarro-Tito N; Ortuño-Pineda C; Leyva-Vázquez MA; Ortíz-Ortíz J; Castro-Coronel Y; Mendoza-Catalán MA
    BMC Complement Med Ther; 2020 Jun; 20(1):191. PubMed ID: 32571387
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TH1902, a new docetaxel-peptide conjugate for the treatment of sortilin-positive triple-negative breast cancer.
    Demeule M; Charfi C; Currie JC; Larocque A; Zgheib A; Kozelko S; Béliveau R; Marsolais C; Annabi B
    Cancer Sci; 2021 Oct; 112(10):4317-4334. PubMed ID: 34314556
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel star-shaped trinuclear platinum(II) complex based on a 1,3,5-triazine core displaying potent antiproliferative activity against TNBC by the mitochondrial injury and DNA damage mechanism.
    Wu Y; Zhao D; Shang J; Huang W; Chen Z
    Dalton Trans; 2022 Jul; 51(29):10930-10942. PubMed ID: 35731536
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-Trop2 antibody-conjugated bioreducible nanoparticles for targeted triple negative breast cancer therapy.
    Son S; Shin S; Rao NV; Um W; Jeon J; Ko H; Deepagan VG; Kwon S; Lee JY; Park JH
    Int J Biol Macromol; 2018 Apr; 110():406-415. PubMed ID: 29055700
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Honokiol nanomicellar formulation produced increased oral bioavailability and anticancer effects in triple negative breast cancer (TNBC).
    Godugu C; Doddapaneni R; Singh M
    Colloids Surf B Biointerfaces; 2017 May; 153():208-219. PubMed ID: 28249200
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Toll-like receptor (TLR) gene expression and immunostimulatory effect of CpG oligonucleotides in hormone receptor positive cell line T47D and triple negative breast cancer cell line MDA-MB-468.
    Natarajan S; Ranganathan M
    Immunopharmacol Immunotoxicol; 2020 Oct; 42(5):408-415. PubMed ID: 32686546
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Macrophage-Derived Extracellular Vesicles as Drug Delivery Systems for Triple Negative Breast Cancer (TNBC) Therapy.
    Haney MJ; Zhao Y; Jin YS; Li SM; Bago JR; Klyachko NL; Kabanov AV; Batrakova EV
    J Neuroimmune Pharmacol; 2020 Sep; 15(3):487-500. PubMed ID: 31722094
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.